Apr 17, 2025 · Anonymous board for Novartis. We’ve seen a growing number of threads touching on AI tools—everything from ChatGPT to internal company initiatives—but mostly in bits and …

3 days ago · Novartis is divulging details from ianalumab’s summertime phase 3 win in a rare autoimmune blood disorder, and the data suggest the treatment could delay the progression of …

Nov 25, 2025 · Shares of Novartis fell 1% on Monday following news of the company's plans to acquire U.S. biotech Avidity Biosciences for about $12 billion, marking the Swiss drugmaker's …

Aug 20, 2020 · Novartis will have to wait a little longer to see if the U.S. Food and Drug Administration (FDA) will greenlight Arzerra (ofatumumab) as a treatment for patients with …

Mar 4, 2025 · Xolair, a 20-year-old asthma drug sold by Roche (ROG.S) and Novartis (NOVN.S) significantly reduced allergic reactions in people with multiple severe food allergies in a late …

Novartis nabbed FDA approval for Kesimpta to treat multiple sclerosis last year, but now it’s getting the thumbs-up from MS patients and nurses.

Anonymous discussion boards for pharmaceutical sales, medical/device sales, lab/diagnostics sales

Apr 26, 2023 · To sharpen its focus on its core therapeutic areas, Novartis is discontinuing or licensing out 10% of its clinical development programs, the company announced Tuesday …

Jan 5, 2026 · Read more about Novartis, Roche unit and others face Italy antitrust probe over eye drug snippet Italy's antitrust regulator said on Thursday it had launched an investigation into …

Jul 25, 2025 · Ribon Therapeutics has named Sudha Parasuraman as its CMO. Parasuraman, last seen occupying the same role at X4 Pharmaceuticals, joins Ribon as it works to use …